Bnp Paribas Arbitrage, Snc »

Jade Biosciences shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Jade Biosciences (JBIO) shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Jade Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Jade Biosciences held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jade Biosciences by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2025-09-30 $129k 15k 8.63
2025-06-30 $32k 3.2k 9.99

More positions owned by Bnp Paribas Arbitrage, Snc

NVIDIA Corp Equity (NVDA)
Microsoft Corp Equity (MSFT)
Meta Platforms Equity (META)
Apple Equity (AAPL)
Tesla Equity (TSLA)
Amazon.com Equity (AMZN)
iShares Core S&P 500 ETF Fund (IVV)
Broadcom Equity (AVGO)
JPMorgan Chase & Co Equity (JPM)
Alphabet Equity (GOOGL)
SPDR S&P 500 ETF Trust Fund (SPY)
iShares Russell 2000 ETF Fund (IWM)
Alphabet Equity (GOOG)
Cisco Systems Equity (CSCO)
General Electric Equity (GE)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Jade Biosciences

FMR
Fairmount Funds Management
VR Adviser
Deep Track Capital
BlackRock
Vanguard Group
Versant Venture Management
Rtw Investments
Frazier Life Sciences Management
Driehaus Capital Management
Avidity Partners Management
RA Capital Management
Soleus Capital Management
Geode Capital Management
Dr. Jeffrey R. Jay, M.D.

View all funds holding Jade Biosciences